1272-P: Fatty Liver Change and Type 2 Diabetes in Older Adults with Prediabetes
Background: No data are available on the association between changes in fatty liver disease (FLD) and the risk of type 2 diabetes in elderly individuals with prediabetes. Methods: A total of 156,984 elderly subjects with prediabetes who underwent national health screening in 2009 and 2011 were follo...
Saved in:
Published in | Diabetes (New York, N.Y.) Vol. 72; no. Supplement_1; p. 1 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
New York
American Diabetes Association
20.06.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Background: No data are available on the association between changes in fatty liver disease (FLD) and the risk of type 2 diabetes in elderly individuals with prediabetes.
Methods: A total of 156,984 elderly subjects with prediabetes who underwent national health screening in 2009 and 2011 were followed up. FLD was defined as a change in the fatty liver index (FLI) with a cut-off of 60 for steatosis and 30 as a reference. Multivariable Cox proportional hazards regression was used to calculate the hazard ratio (HR) and confidence intervals (CIs) for type 2 diabetes according to the changed status of the FLD.
Results: During a median of 8.35 years of follow-up, 29,422 (18.7%) elderly individuals with prediabetes developed type 2 diabetes. Multivariable adjusted HRs of type 2 diabetes according to FLI change were 2.22 (95% CI 2.11-2.34) in individuals with both FLI ≥ 60 compared to those with both FLI < 30. Although weight loss ≥5% was associated with a 7% lower risk of type 2 diabetes (95% CI 0.90-0.96), those with resolved FLD, new FLD, and persistent FLD along with weight loss at the same time period had an increased risk of type 2 diabetes by 30%, 36%, and 53%, respectively. The risk of type 2 diabetes did not increase in individuals with FLD-free status, regardless of weight change.
Conclusions: The presence and change of FLD is an important factor for the development of type 2 diabetes in elderly individuals with prediabetes.
Disclosure
J.Park: None. J.Won: None. |
---|---|
ISSN: | 0012-1797 1939-327X |
DOI: | 10.2337/db23-1272-P |